Travere Therapeutics, Inc. TVTX Income from Discontinued Ops
Discontinued — last reported Q2 '25
Income from Discontinued Ops at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s income from discontinued ops.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s income from discontinued ops?
- Travere Therapeutics, Inc. (TVTX) reported income from discontinued ops of $0.00 in Q2 2025.
- How has Travere Therapeutics, Inc.'s income from discontinued ops changed year-over-year?
- Travere Therapeutics, Inc.'s income from discontinued ops increased by 100.0% year-over-year, from -$0.01 to $0.00.
- What is the long-term trend for Travere Therapeutics, Inc.'s income from discontinued ops?
- Over 3 years (2021 to 2024), Travere Therapeutics, Inc.'s income from discontinued ops has grown at a -74.7% compound annual growth rate (CAGR), from $0.62 to -$0.01.
- What does income from discontinued ops mean?
- Gains or losses from business segments that have been sold, abandoned, or classified as held for sale, reported net of applicable income taxes.